Name of the cohort: KORA

Official homepage of the study. 

Basic characteristics of the study: KORA stands for Cooperative Health Research in the Augsburg Region. Precisely speaking it means a research platform that is used by various national and international research teams. Citizens of the Augsburg region have significantly contributed to the scientific findings by their participation. A representative random sample of all inhabitants between 25 and 74 years was invited to take part. Since 1984 there have been four waves of initial medical examinations at intervals of five years. All nearly 20.000 participants are questioned regularly at intervals of several years with regard to their health condition, and part of them being examined again. This makes it possible to show the progress of a disease over periods of up to more than 20 years. Traditionally, the research focuses on coronary heart diseases, but also other chronic diseases, as e.g., type-2 diabetes, allergies, and lung diseases are being researched now. KORA data also contribute a lot to the investigation of genetic factors.

KORA-gen is a platform to provide phenotypes, genotypes and biosamples for collaborative genetic epidemiological research.
Recently, KORA-PASST, a project application self-service tool, has been established.

Category of the cohort: Mature population-based cohort in adults.

Kind of biomaterials available in the cohorts, i.e. data collected in the cohorts: Serum, plasma, DNA, RNA, salvia, feces.

Application process to access the biomaterials: The applications can be sent via the website.

Cohorts’ data, which can be already used within iMed: Extensive data on risk factors, diseases, OMICS and genetics are available and can be requested for collaboration projects.

Contact person for the KORA Cohort: Prof. Dr. Anette Peters

Contact person for the KORA-gen Cohort: Dr. Martina Müller-Nurasyid

to top